Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 145

1.

Troponin-I as a prognosticator of mortality in severe sepsis patients.

John J, Woodward DB, Wang Y, Yan SB, Fisher D, Kinasewitz GT, Heiselman D.

J Crit Care. 2010 Jun;25(2):270-5. doi: 10.1016/j.jcrc.2009.12.001. Epub 2010 Feb 10.

PMID:
20149590
[PubMed - indexed for MEDLINE]
2.

The effect of drotrecogin alfa (activated) on long-term survival after severe sepsis.

Angus DC, Laterre PF, Helterbrand J, Ely EW, Ball DE, Garg R, Weissfeld LA, Bernard GR; PROWESS Investigators.

Crit Care Med. 2004 Nov;32(11):2199-206.

PMID:
15640631
[PubMed - indexed for MEDLINE]
3.

A retrospective observational study of drotrecogin alfa (activated) in adults with severe sepsis: comparison with a controlled clinical trial.

Wheeler A, Steingrub J, Schmidt GA, Sanchez P, Jacobi J, Linde-Zwirble W, Bates B, Qualy RL, Woodward B, Zeckel M.

Crit Care Med. 2008 Jan;36(1):14-23.

PMID:
18158435
[PubMed - indexed for MEDLINE]
4.

Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death.

Abraham E, Laterre PF, Garg R, Levy H, Talwar D, Trzaskoma BL, François B, Guy JS, Brückmann M, Rea-Neto A, Rossaint R, Perrotin D, Sablotzki A, Arkins N, Utterback BG, Macias WL; Administration of Drotrecogin Alfa (Activated) in Early Stage Severe Sepsis (ADDRESS) Study Group.

N Engl J Med. 2005 Sep 29;353(13):1332-41.

PMID:
16192478
[PubMed - indexed for MEDLINE]
Free Article
5.

International integrated database for the evaluation of severe sepsis and drotrecogin alfa (activated) therapy: analysis of efficacy and safety data in a large surgical cohort.

Payen D, Sablotzki A, Barie PS, Ramsay G, Lowry S, Williams M, Sarwat S, Northrup J, Toland P, Booth FV.

Surgery. 2007 Apr;141(4):548-61.

PMID:
17431957
[PubMed - indexed for MEDLINE]
6.

International integrated database for the evaluation of severe sepsis and drotrecogin alfa (activated) therapy: analysis of efficacy and safety data in a large surgical cohort.

Payen D, Sablotzki A, Barie PS, Ramsay G, Lowry S, Williams M, Sarwat S, Northrup J, Toland P, McL Booth FV.

Surgery. 2006 Nov;140(5):726-39. Corrected and republished in: Surgery. 2007 Apr;141(4):548-61.

PMID:
17084715
[PubMed - indexed for MEDLINE]
7.

International integrated database for the evaluation of severe sepsis and drotrecogin alfa (activated) therapy: 28-day survival and safety.

Laterre PF, Nelson DR, Macias W, Abraham E, Sashegyi A, Williams MD, Levy M, Levi M, Utterback B, Vincent JL.

J Crit Care. 2007 Jun;22(2):142-52. Epub 2007 Jan 31.

PMID:
17548026
[PubMed - indexed for MEDLINE]
8.

The international PROGRESS registry of patients with severe sepsis: drotrecogin alfa (activated) use and patient outcomes.

Martin G, Brunkhorst FM, Janes JM, Reinhart K, Sundin DP, Garnett K, Beale R.

Crit Care. 2009;13(3):R103. doi: 10.1186/cc7936. Epub 2009 Jun 30.

PMID:
19566927
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Hospital mortality and resource use in subgroups of the Recombinant Human Activated Protein C Worldwide Evaluation in Severe Sepsis (PROWESS) trial.

Laterre PF, Levy H, Clermont G, Ball DE, Garg R, Nelson DR, Dhainaut JF, Angus DC.

Crit Care Med. 2004 Nov;32(11):2207-18.

PMID:
15640632
[PubMed - indexed for MEDLINE]
10.

Activated protein C improves survival in severe sepsis patients with elevated troponin.

John J, Awab A, Norman D, Dernaika T, Kinasewitz GT.

Intensive Care Med. 2007 Dec;33(12):2122-8. Epub 2007 Aug 8.

PMID:
17684722
[PubMed - indexed for MEDLINE]
11.

The role of cardiac troponin I as a prognosticator in critically ill medical patients: a prospective observational cohort study.

King DA, Codish S, Novack V, Barski L, Almog Y.

Crit Care. 2005 Aug;9(4):R390-5. Epub 2005 May 31.

PMID:
16137352
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Drotrecogin alfa (activated) administration across clinically important subgroups of patients with severe sepsis.

Ely EW, Laterre PF, Angus DC, Helterbrand JD, Levy H, Dhainaut JF, Vincent JL, Macias WL, Bernard GR; PROWESS Investigators.

Crit Care Med. 2003 Jan;31(1):12-9.

PMID:
12544987
[PubMed - indexed for MEDLINE]
13.

Treatment effects of drotrecogin alfa (activated) in patients with severe sepsis with or without overt disseminated intravascular coagulation.

Dhainaut JF, Yan SB, Joyce DE, Pettilä V, Basson B, Brandt JT, Sundin DP, Levi M.

J Thromb Haemost. 2004 Nov;2(11):1924-33.

PMID:
15550023
[PubMed - indexed for MEDLINE]
14.

Prognostic value of elevated cardiac troponin I in ESRD patients with sepsis.

Kang EW, Na HJ, Hong SM, Shin SK, Kang SW, Choi KH, Lee HY, Han DS, Han SH.

Nephrol Dial Transplant. 2009 May;24(5):1568-73. doi: 10.1093/ndt/gfn730. Epub 2009 Jan 14.

PMID:
19145004
[PubMed - indexed for MEDLINE]
Free Article
15.

Effect of factor V Leiden polymorphism in severe sepsis and on treatment with recombinant human activated protein C.

Yan SB, Nelson DR.

Crit Care Med. 2004 May;32(5 Suppl):S239-46.

PMID:
15118525
[PubMed - indexed for MEDLINE]
16.

Efficacy and safety of drotrecogin alfa (activated) for the therapy of surgical patients with severe sepsis.

Barie PS, Hydo LJ, Shou J, Eachempati SR.

Surg Infect (Larchmt). 2006;7 Suppl 2:S77-80. Review.

PMID:
16895513
[PubMed - indexed for MEDLINE]
17.

Early drotrecogin alpha (activated) administration in severe sepsis is associated with lower mortality: a retrospective analysis of the Canadian ENHANCE cohort.

Hodder RV, Hall R, Russell JA, Fisher HN, Lee B.

Crit Care. 2009;13(3):R78. doi: 10.1186/cc7893. Epub 2009 May 20.

PMID:
19457240
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Severe community-acquired pneumonia as a cause of severe sepsis: data from the PROWESS study.

Laterre PF, Garber G, Levy H, Wunderink R, Kinasewitz GT, Sollet JP, Maki DG, Bates B, Yan SC, Dhainaut JF; PROWESS Clinical Evaluation Committee.

Crit Care Med. 2005 May;33(5):952-61.

PMID:
15891319
[PubMed - indexed for MEDLINE]
19.

Protein C: a potential biomarker in severe sepsis and a possible tool for monitoring treatment with drotrecogin alfa (activated).

Shorr AF, Nelson DR, Wyncoll DL, Reinhart K, Brunkhorst F, Vail GM, Janes J.

Crit Care. 2008;12(2):R45. doi: 10.1186/cc6854. Epub 2008 Apr 4. Review.

PMID:
18394162
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Serum level of cardiac troponin I in pediatric patients with sepsis or septic shock.

Oliveira NS, Silva VR, Castelo JS, Elias-Neto J, Pereira FE, Carvalho WB.

Pediatr Crit Care Med. 2008 Jul;9(4):414-7. doi: 10.1097/PCC.0b013e31817e2b33.

PMID:
18843251
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk